Fluvoxamine does not improve time to sustained recovery in mild COVID-19
For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a study published online Jan. 12 in Journal of the American Medical Association.
Jan 13, 2023
0
13